159 related articles for article (PubMed ID: 15167716)
1. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
2. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
3. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
4. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
8. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
Al-Ruzzeh S; Navia JL
Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
[No Abstract] [Full Text] [Related]
9. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
Stratmann G; Russell IA; Merrick SH
Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
Silver DA; D'Ambra MN
Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
[No Abstract] [Full Text] [Related]
11. Use of recombinant activated factor VII after axillofemoral bypass grafting.
Cheng CA; Ho AM
Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of early bleedings after open-heart surgery].
Shevchenko IuL; Khubulava GG; Krivtsov VA; Bautin AE; Novikov LA
Khirurgiia (Mosk); 1999; (8):28-36. PubMed ID: 10478528
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
[TBL] [Abstract][Full Text] [Related]
17. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
18. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
19. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
Al-Ruzzeh S; Ibrahim K; Navia JL
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
[No Abstract] [Full Text] [Related]
20. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
